Stalevo reduction in dyskinesia evaluation in Parkinson's disease results were expected from a pharmacokinetic viewpoint
- PMID: 21387388
- DOI: 10.1002/ana.22257
Stalevo reduction in dyskinesia evaluation in Parkinson's disease results were expected from a pharmacokinetic viewpoint
Comment on
-
Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study.Ann Neurol. 2010 Jul;68(1):18-27. doi: 10.1002/ana.22060. Ann Neurol. 2010. PMID: 20582993 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
